Skip to main content
logo
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
111.79
+1.28 (1.16%)
Sep 30, 2026, 4:00 PM EDT - Market closed

Kymera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9,2956,2252,6061,4131,3693,259
Market Cap Growth
131.13%138.91%84.43%3.16%-57.98%18.59%
Enterprise Value
7,8695,3301,7831,0597912,666
Last Close Price
110.5177.8140.2325.4624.9663.49

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-34.2734.2734.2734.2734.27
PS Ratio
90.82158.7555.3517.9829.2544.75
PB Ratio
6.063.943.123.582.797.09
P/TBV Ratio
6.323.943.123.582.797.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
77.23135.9337.8713.4716.8836.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.050.110.210.040.04
Net Debt / Equity Ratio
-0.94-0.97-0.91-0.89-1.11-1.20
Net Debt / EBITDA Ratio
4.204.543.042.153.405.55
Net Debt / FCF Ratio
5.996.563.682.563.484.21
Asset Turnover
0.080.030.060.130.080.13
Quick Ratio
9.9710.197.214.595.744.78
Current Ratio
10.3410.477.534.735.884.88
Return on Equity (ROE)
-24.15%-25.78%-36.38%-33.21%-32.60%-26.96%
Return on Assets (ROA)
-15.59%-15.88%-20.65%-17.55%-16.67%-11.50%
Return on Capital Employed (ROCE)
-22.00%-20.80%-28.20%-33.80%-30.30%-19.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.14%-5.00%-8.59%-10.40%-11.30%-3.08%
FCF Yield
-2.50%-3.77%-7.96%-9.72%-11.39%-4.01%
Buyback Yield / Dilution
-17.71%-12.59%-28.58%-8.22%-12.39%-176.60%
SEC Filings: 10-K · 10-Q